Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
London-based Autolus has shown its next-generation CAR T-cell therapy does not induce some of the…
The UK biotech Autolus’ shares have slumped as construction delays from a new manufacturing site…
Here’s the list of the European biotech companies, both public and private, that are worth…
London-based Autolus has made its debut on the NASDAQ raising funds to boost the development of a…
Autolus has revealed a new strategy to treat T-cell lymphoma without harming healthy, protective T…
Autolus, based in London, has raised €68M in Series C to continue developing its T cell…
You have roughly 50% chance of developing a cancer in your life and 25% of…